-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Hold on Edwards Lifesciences, Raises Price Target to $89

Benzinga·12/05/2025 19:12:38
语音播报
Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $84 to $89.